Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Study the Impact of CPAP on Gait Parameters in OSA Patients (OSA_Gait)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02061046
Recruitment Status : Unknown
Verified November 2015 by Gilles Allali, University Hospital, Geneva.
Recruitment status was:  Active, not recruiting
First Posted : February 12, 2014
Last Update Posted : December 2, 2015
Sponsor:
Information provided by (Responsible Party):
Gilles Allali, University Hospital, Geneva

Brief Summary:
To study the impact of CPAP therapy on gait in patients with obstructive sleep apnea syndrome.

Condition or disease Intervention/treatment
Obstructive Sleep Apnea Device: CPAP therapy

Detailed Description:
To study the impact of CPAP therapy on gait velocity and temproral gait in patients with obstructive sleep apnea syndrome using the SMTEC system. Patients will be assessed before and 8 weeks after CPAP therapy.

Layout table for study information
Study Type : Observational
Actual Enrollment : 35 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Impact of the CPAP on Gait in OSA Patients
Study Start Date : August 2009
Actual Primary Completion Date : August 2009
Estimated Study Completion Date : May 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea

Group/Cohort Intervention/treatment
On CPAP therapy
OSA patients assessed before and after 8 weeks of CPAP therapy
Device: CPAP therapy
8 weeks of CPAP therapy




Primary Outcome Measures :
  1. Gait parameters: gait velocity [m/s] [ Time Frame: 8 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
OSA patients without any prior treatment
Criteria

Inclusion Criteria:

  • OSA patients newly diagnosed

Exclusion Criteria:

  • acute medical illness in the past months
  • neurological and psychiatric diseases
  • orthopaedic, rheumatologic or any sensory conditions affecting normal walking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02061046


Locations
Layout table for location information
Switzerland
Geneva University Hospitals
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Layout table for investigator information
Principal Investigator: Gilles Allali, MD/PhD University Hospital, Geneva

Layout table for additonal information
Responsible Party: Gilles Allali, Dr, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT02061046     History of Changes
Other Study ID Numbers: PRD 10-II-7
First Posted: February 12, 2014    Key Record Dates
Last Update Posted: December 2, 2015
Last Verified: November 2015

Keywords provided by Gilles Allali, University Hospital, Geneva:
Gait
Dual task

Additional relevant MeSH terms:
Layout table for MeSH terms
Sleep Apnea, Obstructive
Sleep Apnea Syndromes
Apnea
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases